Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Cancer-Associated Fibroblasts in Prostate Cancer Tumorigenesis
Francesco Bonollo, George N. Thalmann, Marianna Kruithof‐de Julio, et al.
Cancers (2020) Vol. 12, Iss. 7, pp. 1887-1887
Open Access | Times Cited: 122

Showing 26-50 of 122 citing articles:

Single-Cell RNA Sequencing Identifies CCR6-Driven Immune Landscape Changes in RM1 Prostate Cancer Bone Metastasis
Marxa L. Figueiredo
DNA and cell biology reports. (2025) Vol. 6, Iss. 1, pp. 1-10
Closed Access
Bioengineered Tumor‐Stroma Prostate Cancer In Vitro Models for Screening Therapeutics
Maria V. Monteiro, Filipa Moreira‐Silva, Matilde R. Lagarto, et al.
Biotechnology and Bioengineering (2025)
Closed Access
Exploring TGF-β signaling in benign prostatic hyperplasia: from cellular senescence to fibrosis and therapeutic implications
Abida Khan, Hayat Alzahrani, Shatha Ghazi Felemban, et al.
Biogerontology (2025) Vol. 26, Iss. 2
Closed Access
Immunotherapy in Advanced Prostate Cancer—Light at the End of the Tunnel?
Gunhild von Amsberg, Winfried Alsdorf, Panagiotis Karagiannis, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2569-2569
Open Access | Times Cited: 18
Interplay between Prostate Cancer and Adipose Microenvironment: A Complex and Flexible Scenario
Mathilde Cancel, William Pouillot, Karine Mahéo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10762-10762
Open Access | Times Cited: 16
Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives
Felicia Maria Maselli, Francesco Giuliani, Carmelo Laface, et al.
Current Oncology (2023) Vol. 30, Iss. 6, pp. 5769-5794
Open Access | Times Cited: 10
PRADclass: Hybrid Gleason Grade-Informed Computational Strategy Identifies Consensus Biomarker Features Predictive of Aggressive Prostate Adenocarcinoma
Alex Stanley Balraj, Sangeetha Muthamilselvan, Rachanaa Raja, et al.
Technology in Cancer Research & Treatment (2024) Vol. 23
Open Access | Times Cited: 3
Mechanistic Characterization of Cancer Associated Fibroblast Depletion via an Antibody-Drug Conjugate Targeting Fibroblast Activation Protein
Joseph P. Gallant, Hallie M. Hintz, Gihan S. Gunaratne, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 6, pp. 1481-1494
Open Access | Times Cited: 3
Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients
Marianna Talia, Eugenio Cesario, Francesca Cirillo, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Therapy resistance in prostate cancer: mechanism, signaling and reversal strategies
N.P. THAKUR, Pallavi Singh, Aditi Bagri, et al.
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 5, pp. 1110-1134
Open Access | Times Cited: 3
Immune-related gene index predicts metastasis for prostate cancer patients undergoing radical radiotherapy
Dechao Feng, Weizhen Zhu, Xu Shi, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 9
SFRP1 induces a stem cell phenotype in prostate cancer cells
Alberto Losada-García, Iván Salido-Guadarrama, Sergio Alberto Cortes-Ramirez, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 9
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer
Joakin Mori, Isra Elhussin, W. Nathaniel Brennen, et al.
Nature Reviews Urology (2023) Vol. 21, Iss. 5, pp. 258-273
Closed Access | Times Cited: 9
Cancer-Associated Fibroblast Induces Acinar-to-Ductal Cell Transdifferentiation and Pancreatic Cancer Initiation Via LAMA5/ITGA4 Axis
Seema Parte, Annant Bir Kaur, Rama Krishna Nimmakayala, et al.
Gastroenterology (2023) Vol. 166, Iss. 5, pp. 842-858.e5
Closed Access | Times Cited: 9
Cancer Biology and Therapeutics: Navigating Recent Advances and Charting Future Directions

Tropical Journal of Natural Product Research (2023) Vol. 7, Iss. 12
Open Access | Times Cited: 9
New insights and options into the mechanisms and effects of combined targeted therapy and immunotherapy in prostate cancer
Mingen Lin, Xue Sun, Lei Lv
Molecular Therapy — Oncolytics (2023) Vol. 29, pp. 91-106
Open Access | Times Cited: 8
Evaluation of Glutaminase Expression in Prostate Adenocarcinoma and Correlation with Clinicopathologic Parameters
Zin Myint, Ramon C. Sun, Patrick J. Hensley, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2157-2157
Open Access | Times Cited: 20
Novel Combinatorial Approaches to Tackle the Immunosuppressive Microenvironment of Prostate Cancer
Erin G. Shackleton, Haleema Yoosuf Ali, Masood A. Khan, et al.
Cancers (2021) Vol. 13, Iss. 5, pp. 1145-1145
Open Access | Times Cited: 19
Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment
Raquel Muñoz, Alessandra Girotti, Denise Hileeto, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5414-5414
Open Access | Times Cited: 19
Stromal cell interplay in prostate development, physiology, and pathological conditions
Bruno D. A. Sanches, Juliana S. Maldarine, Patrícia Simone Leite Vilamaior, et al.
The Prostate (2021) Vol. 81, Iss. 13, pp. 926-937
Closed Access | Times Cited: 18
Focus on the tumor microenvironment: A seedbed for neuroendocrine prostate cancer
Hengfeng Zhou, Qiangrong He, Chao Li, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 14
A comprehensive review on the molecular basis and therapeutic targets in prostate cancer
Florentina Claudia Militaru, Valentin Militaru, Nicolae Crișan, et al.
Biomolecules and Biomedicine (2023)
Open Access | Times Cited: 7
Immune Checkpoint Inhibitors: A Promising Treatment Option for Metastatic Castration-Resistant Prostate Cancer?
Vicenç Ruiz de Porras, Juan Carlos Pardo, L. Notario, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4712-4712
Open Access | Times Cited: 16
Patterns of indolence in prostate cancer (Review)
Minas Sakellakis, Laura Jacqueline Flores, Sumankalai Ramachandran
Experimental and Therapeutic Medicine (2022) Vol. 23, Iss. 5
Open Access | Times Cited: 12
Ephrin B Activate Src Family Kinases in Fibroblasts Inducing Stromal Remodeling in Prostate Cancer
Mamatha Kakarla, Sathyavathi ChallaSivaKanaka, Mary F. Dufficy, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2336-2336
Open Access | Times Cited: 12

Scroll to top